Lonza – Your Partner in Immunotherapy Research

If you’re ready for the clinic, our cell therapy services might be the answer you need

Written byLonza
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Lonza is committed to supporting your immunotherapy research by providing primary cells, media and both large- and small-volume transfection solutions to help your transition from research into therapy. If you’re ready for the clinic, our cell therapy services might be the answer you need for development, manufacturing and testing of your cell-based therapeutics.

Cells and Media

Whether you need purified natural killer cells, a mixed population of PBMCs, or unprocessed bone marrow, Lonza has the optimal cell and media solution you’re looking for. If you don’t see it in our catalog, we can likely isolate cells for you through our Cells on Demand Service.

Transfection

Lonza’s Large-Volume 4D-Nucleofector™ LV Unit can transfect up to 1x109 cells without the need for re-optimization from your smaller-scale format. With this new addition to the established 4D-Nucleofector™ System, small- and large-scale transfection applications are seamless!

Clinical Cell Therapy Services

We partner with clients to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery